Segment disclosures

Company overview

Roivant Sciences Ltd.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 13 retained observations 9 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Reportable Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=roiv:ReportableSegmentMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-301442000 USD20260806Open filing evidence
2025-04-01 – 2026-03-318260000 USD20260520Open filing evidence
2025-10-01 – 2025-12-311999000 USD20260206Open filing evidence
2025-04-01 – 2025-12-315740000 USD20260206Open filing evidence
2025-07-01 – 2025-09-301571000 USD20251110Open filing evidence
2025-04-01 – 2025-09-303741000 USD20251110Open filing evidence
2025-04-01 – 2025-06-302170000 USD20260806Open filing evidence
2024-04-01 – 2025-03-3129053000 USD20260520Open filing evidence
2024-10-01 – 2024-12-319018000 USD20260206Open filing evidence
2024-04-01 – 2024-12-3121483000 USD20260206Open filing evidence
2024-07-01 – 2024-09-304475000 USD20251110Open filing evidence
2024-04-01 – 2024-09-3012465000 USD20251110Open filing evidence
2023-04-01 – 2024-03-3132713000 USD20260520Open filing evidence